Skip to search formSkip to main contentSkip to account menu

Myeloablative Agonists

Known as: Agonist, Myeloablative, Agonists, Myeloablative, Myeloablative Agonist 
Agents that destroy bone marrow activity. They are used to prepare patients for BONE MARROW TRANSPLANTATION or STEM CELL TRANSPLANTATION.
National Institutes of Health

Related topics

Related topics

10 relations

Narrower (4)

BusulfanCyclophosphamideMelphalanThiotepa
In Bloodagonistsantagonists & inhibitorsaspects of radiation effects

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402
Epidermal growth factor (EGF) is a recently described biomarker of acute GvHD (aGvHD). Whether low plasma EGF prior to… 
2014
2014
Early engraftment and full-donor chimerism after single-cord blood plus third-party donor dual transplantation in patients with high-risk acute leukemia
Early engraftment and full-donor chimerism after single-cord blood plus third-party donor dual transplantation in patients with… 
2013
2013
The Use of Tevagrastim (Biosimilar Filgrastim XMO2) for Hematopoietic Stem Cell Mobilization in HLA Matched Sibling Donors for Allogeneic Stem Cell Transplantation to AML/MDS Patients
2011
2011
Comparison of reduced intensity and myeloablative conditioning regimens for stem cell transplantation in patients with malignancies: a meta‐analysis
Shi‐Xia X, Hai‐Qin X, Xian‐Hua T, Bo F, Xiang‐Feng T. Comparison of reduced intensity and myeloablative conditioning regimens for… 
2011
2011
A randomized, phase III trial comparing BuCy and BuFlu as a myeloablative conditioning regimen.
6524 Background: Although busulfan-cyclophosphamide (BuCy) has been commonly used as a myeloablative conditioning (MC) regimen… 
2007
2007
Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides
Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for… 
Review
2007
Review
2007
Home administration of high-dose oral busulfan in patients undergoing hematopoietic stem cell transplantation
We report our experience with oral busulfan (BU) in 159 consecutive patients to evaluate the safety of home administration… 
Review
2006
Review
2006
Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options
Myeloablative sibling-matched allogeneic transplantation for adult acute lymphoblastic leukaemia provides the best outcome, but… 
Review
2003
Review
2003
Treatment concepts for elderly patients with acute myeloid leukemia
ZusammenfassungDer überwiegende Anteil der Patienten mit akuter myeloischer Leukämie (AML) ist bei Diagnosestellung bereits älter… 
1992
1992
Immunomagnetic Removal of Malignant Cells from Human Bone Marrow Prior to Autologous Bone Marrow Transplantation
Autologous bone marrow transplantation (ABMT) following myeloablative chemoradiotherapy is an alternative to conventional… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)